Inventor · disambiguated record
Brett C. Bookser
Also filed as: BOOKSER BRETT · BOOKSER BRETT C
21 granted patents·9 pending applications·95 citations·filing 1994–2024
93Inventor score
Files withDART NEUROSCIENCE LLC7METABASIS THERAPEUTICS INC7VERTEX PHARMA5DART NEUROSCIENCE CAYMAN LTD2HECKER SCOTT J2
Top patents by PatentIndex Score
30 records- 0188US6919322B2Phenyl Phosphonate Fructose-1,6-Bisphosphatase InhibitorsMETABASIS THERAPEUTICS INC·Filed 2001·Granted Jul 19, 2005·28 cites·56 claims
- 0286US8962618B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofREDDY K RAJA·Filed 2012·Granted Feb 24, 2015·7 cites·6 claims
- 0385US10034891B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2016·Granted Jul 31, 2018·2 cites·4 claims
- 0485US8063025B2Nucleoside prodrugs and uses thereofHECKER SCOTT J·Filed 2008·Granted Nov 22, 2011·11 cites·18 claims
- 0582US11434247B1Substituted furanopyrimidine compounds as PDE1 inhibitorsDART NEUROSCIENCE LLC·Filed 2018·Granted Sep 6, 2022·2 cites·24 claims
- 0682US9340566B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2015·Granted May 17, 2016·2 cites·10 claims
- 0780US7371739B2Aryl fructose-1,6-bisphosphatase inhibitorsMETABASIS THERAPEUTICS INC·Filed 2005·Granted May 13, 2008·4 cites·79 claims
- 0879US8940927B2Activators of glucokinaseTIAN FENG·Filed 2011·Granted Jan 27, 2015·4 cites·31 claims
- 0978US11365191B2Substituted cyclohexyl compounds as NOP inhibiiorsDART NEUROSCIENCE LLC·Filed 2019·Granted Jun 21, 2022·2 cites·25 claims
- 1078US2025145633A1Substituted furanopyrimidine compounds as pde1 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 1177US9708334B2Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitorsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Jul 18, 2017·2 cites·20 claims
- 1277US2025092024A1Substituted cyclohexyl compounds as nop inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 1376US10709718B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2018·Granted Jul 14, 2020·1 cites·11 claims
- 1475US12006325B2Substituted furanopyrimidine compounds as PDE1 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Granted Jun 11, 2024·0 cites·20 claims
- 1574US11945808B2Substituted cyclohexyl compounds as NOP inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Granted Apr 2, 2024·0 cites·20 claims
- 1674US2025179091A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1771US8394969B2Cyclic benzimidazole derivatives useful as anti-diabetic agentsBOOKSER BRETT C·Filed 2009·Granted Mar 12, 2013·4 cites·19 claims
- 1868US5731432AInhibitors of adenosine monophosphate deaminaseGENSIA SICOR INC·Filed 1994·Granted Mar 24, 1998·26 cites·41 claims
- 1964US12269831B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Granted Apr 8, 2025·0 cites·41 claims
- 2061US2025122218A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2159US9522926B2Activators of glucokinaseMETABASIS THERAPEUTICS INC·Filed 2014·Granted Dec 20, 2016·0 cites·56 claims
- 2256US12324802B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Granted Jun 10, 2025·0 cites·53 claims
- 2355US2023339886A1Rev-erb agonists for the treatment of th17-mediated inflammatory disordersUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 2453US2024342185A1SMALL MOLECULES INHIBITORS OF CYCLIC GMP-AMP SYNTHASE (cGAS)SCRIPPS RESEARCH INST·Filed 2022·Application pending·0 cites
- 2551US10174062B2Activators of glucokinaseMETABASIS THERAPEUTICS INC·Filed 2016·Granted Jan 8, 2019·0 cites·35 claims
- 2650US2022313698A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Application pending·0 cites
- 2745US8410284B2Cyclic benzimidazole derivatives useful as anti-diabetic agentsDANG QUN·Filed 2009·Granted Apr 2, 2013·0 cites·17 claims
- 2843US2012039845A1Nucleoside prodrugs and uses thereofHECKER SCOTT J·Filed 2011·Application pending·0 cites
- 2941US2019177327A1Substituted methyl pyrazolopyrimidinone and methyl imidazopyrazinone compounds as pde1 inhibitorsDART NEUROSCIENCE LLC·Filed 2018·Application pending·0 cites
- 3036US10040759B2Substituted azetidinyl compounds as GlyT1 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2015·Granted Aug 7, 2018·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Brett C. Bookser files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →